THE UNITED LABORATORIES INTERNATIONAL HOLDINGS LIMITED

Other languages The United Laboratories International Holdings Limited

Equities

3933

KYG8813K1085

Market Closed - Hong Kong S.E. Other stock markets 09:08:20 26/04/2024 BST			5-day change	1st Jan Change
9.48 ^HKD	-2.97%		-1.15%	+35.24%

03-27	The United Laboratories International Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
03-27	The United Laboratories International's 2023 Profit Rises on Higher Revenue	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

The United Laboratories International Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	03-27
The United Laboratories International's 2023 Profit Rises on Higher Revenue	03-27
The United Laboratories International Holdings Limited Recommends Payment of Final Dividend for the Year Ended 31 December 2023	03-26
The United Laboratories International Holdings Limited Recommends Payment of Special Dividend for the Year Ended 31 December 2023	03-26
The United Laboratories International Forecasts Profit Surge in 2023	03-15
The United Laboratories International Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023	03-14
United Laboratories Postpones EGM Due to Bad Weather	09/10/23
United Laboratories Subsidiary Gets US FDA Nod for Injectable for Diabetes; Shares Rise 8%	27/09/23
The United Laboratories International Holdings Limited Announces FDA Approval of IND for UBT251 Injection	26/09/23
The United Laboratories International Holdings Limited Announces Interim Dividend for Six Months Ended 30 June 2023, Payable on 11 October 2023	21/09/23
United Laboratories Controlling Shareholder to Sell 64 Million Shares	19/09/23
United Laboratories International Unit Gets Regulatory Nod to Conduct Trial on TUL01101 Tablets	11/09/23
Chinese Regulator Allows Clinical Trial of United Laboratories' Fatty-Liver Drug	08/09/23
The United Laboratories International Holdings Limited Announces Application for the Clinical Trial of Class 1 Innovative New Drug UBT251 Injection	08/09/23
United Laboratories International Says Two Products Pass Consistency Evaluation	07/09/23
China Greenlights United Laboratories' Clinical Trial for Obesity Injection; Shares Rise 4%	04/09/23
The United Laboratories International Holdings Limited Announces Approval for Clinical Trial of Ubt251 Injection on Indication of Overweight or Obesity	03/09/23
The United Laboratories International Holdings Limited Announces Ordinary Interim (Semi-Annual) Dividend for Six Months Ended 30 June 2023	30/08/23
United Laboratories' H1 Profit Doubles; Shares Fall 4%	30/08/23
The United Laboratories International Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages The United Laboratories International Holdings Limited

Equities

3933

KYG8813K1085

Other languages

Filters